IKS Health Wins Three Black Book Research Awards 2026 for AI-Driven RCM, Medical Coding, and Clinical Documentation
IKS Health Secures Multiple Top Rankings in 2026 Black Book Survey
Mumbai and Dallas, March 19: IKS Health, a global care enablement solutions provider, has secured three major honors at the 2026 Black Book Research awards. The company was recognized for AI-driven revenue cycle management for the second consecutive year, medical coding for the fourth straight year, and clinical documentation and AI services for the 13th consecutive year.These recognitions reflect continued client endorsement of IKS Health’s focus on accountability, technology integration, and measurable outcomes aimed at optimizing healthcare revenue systems.
Sachin K. Gupta, Founder and Global CEO of IKS Health, said the company remains committed to delivering intelligent healthcare solutions that combine AI capabilities with human expertise.
Rising Demand for AI-Driven Healthcare Services
Black Book Research highlighted strong growth expectations across all three segments, pointing to a broader industry shift toward outcomes-based contracting and integrated service delivery.In AI-driven revenue cycle management services, 35 percent to 55 percent of surveyed providers expect to increase spending in 2026, with 45 percent to 70 percent anticipating further growth in 2027.
Similarly, outsourced medical coding is expected to see spending increases of 35 percent to 55 percent in 2026 and 40 percent to 60 percent in 2027.
Clinical documentation services are also projected to grow, driven by rising clinician workload, increasing complexity in specialty documentation, and continued investments in improving provider experience. Additional growth factors include integration with clinical documentation improvement, quality reporting, and revenue integrity functions.
AI-Driven RCM: IKS Health Ranked No. 1
IKS Health secured the top position in AI-driven RCM services based on a survey of 1,037 respondents across healthcare organizations.The company ranked No. 1 in nine key performance indicators, including denial prevention, claim optimization, AI-driven revenue protection, administrative burden reduction, predictive denial analytics, compliance with payer rules, and cybersecurity standards.
Leadership in Medical Coding Services
In the medical coding category, IKS Health was also ranked No. 1, leading in nine performance areas such as code set change management, complex procedural coding, quality assurance, workforce training, reporting transparency, and innovation in automation.The rankings were based on feedback from healthcare providers, hospitals, and ancillary care facilities.
Clinical Documentation and AI Services Dominate Rankings
IKS Health’s clinical documentation solutions achieved the top rank in 14 performance indicators in a survey of 1,146 users across healthcare settings.Key strengths included strategic alignment with regulatory priorities, innovation, training, scalability, system reliability, data security, and customer support.
Industry Recognition Reflects Measurable Outcomes
Doug Brown, Founder of Black Book Research, noted that healthcare buyers are increasingly favoring vendors capable of delivering measurable outcomes through technology and operational excellence.He stated that IKS Health’s consistent performance across multiple categories highlights its ability to meet evolving industry demands for accountability and efficiency.
About Black Book Research
Black Book Research is an independent healthcare technology and services research firm that evaluates vendors based on verified user satisfaction, benchmarking, and operational performance.About IKS Health
IKS Health focuses on reducing administrative and clinical burdens in healthcare through its care enablement platform, which integrates AI, workflow automation, and human expertise. The company partners with major health systems and physician groups across the United States.Inventurus Knowledge Solutions Limited is listed on the National Stock Exchange of India and the Bombay Stock Exchange under the symbols IKS and 544309 PWR.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.